carbostyril has been researched along with Conjunctivitis, Allergic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, A; Jain, AK; Malhotra, C; Ram, J; Singh, H | 1 |
| Kinoshita, S; Sotozono, C; Ueta, M; Yokoi, N | 1 |
| Kinoshita, S; Koga, A; Sotozono, C; Ueta, M; Yokoi, N | 1 |
| Bonini, S; Brovarone, FV; Miglior, M; Negrini, A; Pezzi, PP; Ruggieri, ML; Scullica, L; Secchi, AG; Vargiu, G | 1 |
| Blumenthal, M; Casale, T; Dockhorn, R; Jarmoszuk, I; Kaiser, H; Smith, R; Zeitz, HJ | 1 |
| Ennevaara, K; Latvala, AL; Leino, M; Nordgren, P; Posti, AM; Suves, R; Takalo, E | 1 |
| Allansmith, MR; Barney, NP; Berruto, A; Bonini, S; Centofanti, M; Schiavone, M | 1 |
| Carlson, C; Jaanio, E; Koivunen, T; Lavikkala, H; Leino, M; Riihelä, K; Takalo, E | 1 |
5 trial(s) available for carbostyril and Conjunctivitis, Allergic
| Article | Year |
|---|---|
Nedocromil sodium and astemizole, alone or combined, in the treatment of seasonal allergic conjunctivitis. A multicentre double blind clinical trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Astemizole; Child; Conjunctivitis, Allergic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nedocromil; Quinolones | 1993 |
Efficacy and safety of nedocromil sodium ophthalmic solution in the treatment of seasonal allergic conjunctivitis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Conjunctivitis, Allergic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Nedocromil; Ophthalmic Solutions; Quinolones | 1992 |
Double-blind group comparative study of 2% nedocromil sodium eye drops with 2% sodium cromoglycate and placebo eye drops in the treatment of seasonal allergic conjunctivitis.
Topics: Adult; Conjunctivitis, Allergic; Cromolyn Sodium; Double-Blind Method; Drug Administration Schedule; Humans; Mast Cells; Nedocromil; Ophthalmic Solutions; Pollen; Quinolones; Seasons | 1992 |
Effectiveness of nedocromil sodium 2% eyedrops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Child; Conjunctivitis, Allergic; Double-Blind Method; Female; Humans; Hyperemia; Male; Nedocromil; Ophthalmic Solutions; Pruritus; Quinolones; Tears | 1992 |
Double-blind group comparative study of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Conjunctivitis, Allergic; Double-Blind Method; Humans; Nedocromil; Ophthalmic Solutions; Quinolones | 1990 |
3 other study(ies) available for carbostyril and Conjunctivitis, Allergic
| Article | Year |
|---|---|
Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
Topics: Administration, Topical; Alanine; Conjunctivitis, Allergic; Cyclosporine; Humans; Immunologic Factors; Immunosuppressive Agents; Ointments; Ophthalmic Solutions; Prospective Studies; Quinolones; Tacrolimus; Treatment Outcome | 2022 |
Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells.
Topics: Alanine; Animals; Antioxidants; Conjunctiva; Conjunctivitis, Allergic; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Humans; Inflammation; Interferon Inducers; Mice; Mice, Inbred BALB C; Poly I-C; Quinolones; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2013 |
Usefulness of a new therapy using rebamipide eyedrops in patients with VKC/AKC refractory to conventional anti-allergic treatments.
Topics: Adolescent; Adult; Alanine; Anti-Allergic Agents; Child; Conjunctivitis, Allergic; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Quinolones; Treatment Outcome; Young Adult | 2014 |